European Commission approves revolutionary prostate cancer drug co-developed by Czech scientist
Kort samengevat
The European Commission recently approved a new prostate cancer drug called Pluvicto, co-developed by a Czech researcher.
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij Radio Prague International.
Lees het volledige bericht โ